Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The comings and goings of PARP-1 in response to DNA damage
John M. Pascal
DNA repair (2018) Vol. 71, pp. 177-182
Open Access | Times Cited: 299

Showing 1-25 of 299 citing articles:

NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Na Xie, Lu Zhang, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 653
Poly(ADP-ribose) polymerase inhibition: past, present and future
Nicola J. Curtin, Csaba Szabó
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 10, pp. 711-736
Closed Access | Times Cited: 403
Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies
Gagan K. Gupta, Amber L. Collier, Dasom Lee, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2392-2392
Open Access | Times Cited: 243
HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation
Marcin J. Suskiewicz, Florian Zobel, T.E.H. Ogden, et al.
Nature (2020) Vol. 579, Iss. 7800, pp. 598-602
Open Access | Times Cited: 219
Mitochondrial dysfunction in the development and progression of neurodegenerative diseases
Joseph Johnson, Elizabeth Mercado‐Ayón, Yesica Mercado-Ayon, et al.
Archives of Biochemistry and Biophysics (2020) Vol. 702, pp. 108698-108698
Closed Access | Times Cited: 194
Multifaceted Role of PARP-1 in DNA Repair and Inflammation: Pathological and Therapeutic Implications in Cancer and Non-Cancer Diseases
Simonetta Pazzaglia, Claudio Pioli
Cells (2019) Vol. 9, Iss. 1, pp. 41-41
Open Access | Times Cited: 172
PARP family enzymes: regulation and catalysis of the poly(ADP-ribose) posttranslational modification
Marie-France Langelier, Travis Eisemann, Amanda A. Riccio, et al.
Current Opinion in Structural Biology (2018) Vol. 53, pp. 187-198
Open Access | Times Cited: 163
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma
Matteo Rosellini, Andrea Marchetti, Veronica Mollica, et al.
Nature Reviews Urology (2022) Vol. 20, Iss. 3, pp. 133-157
Closed Access | Times Cited: 149
ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells
Priyanka Verma, Yeqiao Zhou, Zhendong Cao, et al.
Nature Cell Biology (2021) Vol. 23, Iss. 2, pp. 160-171
Open Access | Times Cited: 122
Recent advances in DDR (DNA damage response) inhibitors for cancer therapy
Binbin Cheng, Wei Pan, Yi Xing, et al.
European Journal of Medicinal Chemistry (2022) Vol. 230, pp. 114109-114109
Closed Access | Times Cited: 87
Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions
Jindi Huang, Liye Chen, Jiangxia Wu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16033-16061
Closed Access | Times Cited: 74
Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors
Shovan Dutta, Anirban Ganguly, Kaushiki Chatterjee, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 218-218
Open Access | Times Cited: 74
Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies
Antonella Padella, Andrea Ghelli Luserna di Rorà, Giovanni Marconi, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 71
Bridging of DNA breaks activates PARP2–HPF1 to modify chromatin
Silvija Bilokapić, Marcin J. Suskiewicz, Ivan Ahel, et al.
Nature (2020) Vol. 585, Iss. 7826, pp. 609-613
Open Access | Times Cited: 119
Carotenoids in Cancer Apoptosis—The Road from Bench to Bedside and Back
Lenka Koklesová, Alena Líšková, Marek Samec, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2425-2425
Open Access | Times Cited: 95
An HPF1/PARP1-Based Chemical Biology Strategy for Exploring ADP-Ribosylation
Juán José Bonfiglio, Orsolya Leidecker, Helen Dauben, et al.
Cell (2020) Vol. 183, Iss. 4, pp. 1086-1102.e23
Open Access | Times Cited: 90
Role of Rad51 and DNA repair in cancer: A molecular perspective
Erik Laurini, Domenico Marson, Alice Fermeglia, et al.
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107492-107492
Open Access | Times Cited: 88
ADP-ribosylation of DNA and RNA
Joséphine Groslambert, Evgeniia Prokhorova, Ivan Ahel
DNA repair (2021) Vol. 105, pp. 103144-103144
Open Access | Times Cited: 80
Real-time monitoring of PARP1-dependent PARylation by ATR-FTIR spectroscopy
Annika Krüger, Alexander Bürkle, Karin Hauser, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 79
Serine-linked PARP1 auto-modification controls PARP inhibitor response
Evgeniia Prokhorova, Florian Zobel, Rebecca Smith, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 77
Parp1 promotes sleep, which enhances DNA repair in neurons
David Zada, Yaniv Sela, Noa Matosevich, et al.
Molecular Cell (2021) Vol. 81, Iss. 24, pp. 4979-4993.e7
Open Access | Times Cited: 77
DNA–protein crosslink proteases in genome stability
Annamaria Ruggiano, Kristijan Ramadan
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 72
ADP-ribosylation of RNA and DNA: fromin vitrocharacterization toin vivofunction
Lisa Weixler, Katja Schäringer, Jeffrey Momoh, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 7, pp. 3634-3650
Open Access | Times Cited: 68
PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
Lotte van Beek, Éilís McClay, Saleha Patel, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5112-5112
Open Access | Times Cited: 68
Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets
Kharimat Lora Alatise, Samantha Gardner, Angela Alexander-Bryant
Cancers (2022) Vol. 14, Iss. 24, pp. 6246-6246
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top